Concepedia

Emily S. Reese

ES

5

Publications

181

Citations

5

H-Index

2010

Active since

Affiliations

Levine Cancer Institute(Current)

University of Maryland, Baltimore

Emily S. Reese is an author at Levine Cancer Institute specializing in clinical trials, education, and comparative effectiveness research.

ORCID

Top concepts

Publications per year

2010–2025

5

Publications

5

Cost‐Effectiveness of Cytochrome P450 2C19 Genotype Screening for Selection of Antiplatelet Therapy with Clopidogrel or Prasugrel

Emily S. Reese, C. Daniel Mullins, Amber L. Beitelshees et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2012 · 83 citations · Full text

Generating Evidence for Comparative Effectiveness Research Using More Pragmatic Randomized Controlled Trials

C. Daniel Mullins, Danielle Whicher, Emily S. Reese et al. · PharmacoEconomics · 2010 · 35 citations

, , +9

Evaluation of <scp>CYP</scp>2C19 Genotype‐Guided Voriconazole Prophylaxis After Allogeneic Hematopoietic Cell Transplant

Jai N. Patel, Issam S. Hamadeh, Myra Robinson et al. · Clinical Pharmacology & Therapeutics · 2019 · 33 citations

Safety and Cost Benefits of the Rapid Daratumumab Infusion Protocol

Issam S. Hamadeh, Emily S. Reese, Justin Arnall et al. · Clinical Lymphoma Myeloma & Leukemia · 2020 · 17 citations

, , +6

Medical Policy Determinations for Pharmacogenetic Tests Among US Health Plans

Jai N. Patel, Lena Chaihorsky, Olivia M Dong et al. · The American Journal of Managed Care · 2025 · 13 citations

Rows per page

1–5 of 5